Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Núñez-Arias

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinics and Practice|June 25, 2026
Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic StudyAna María de Granda-Beltrán, Alejandro Porras-Segovia, Daniel Núñez-Arias, et al.
Spanish Journal of Psychiatry and Mental Health|April 9, 2024
Epidemiological characteristics and hospitalization trajectories prior to suicide in Galicia between 2013 and 2016Vanessa Blanco, María Tajes Alonso, Luisa F Peleteiro Pensado, et al.
International Journal of Psychiatry in Clinical Practice|July 6, 2022
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practiceDavid Fraguas, David Almenta Gallego, Sergio Arques-Egea, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinics and Practice|June 25, 2026
Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic StudyAna María de Granda-Beltrán, Alejandro Porras-Segovia, Daniel Núñez-Arias, et al.
Spanish Journal of Psychiatry and Mental Health|April 9, 2024
Epidemiological characteristics and hospitalization trajectories prior to suicide in Galicia between 2013 and 2016Vanessa Blanco, María Tajes Alonso, Luisa F Peleteiro Pensado, et al.
International Journal of Psychiatry in Clinical Practice|July 6, 2022
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practiceDavid Fraguas, David Almenta Gallego, Sergio Arques-Egea, et al.
Pageof 1